Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
10 practical tips to make type 1 diabetes work for you tlc retreat 2013 ponder
1. 10 practical tips to help make
type 1 diabetes work for you!
Stephen W. Ponder MD, FAAP, CDE
Professor of Pediatrics
Pediatric Endocrinologist
Scott & White Healthcare
Medical Director, Diabetes Camping Sessions
Temple, Round Rock, College Station
2. Today’s agenda
1.
2.
3.
4.
5.
Understand what you are really
trying to manage with diabetes:
FLUX and DRIFT
Know how your tools are
supposed to be used and how
they work (insulin, food,
exercise, monitors, pumps)
Appreciate the limitations of
your tools, technology and
yourself or the PWD/CWD
Be able to recognize a trend or
pattern from randomness or
poor technique
Understand when and how to
make prudent changes to the Dmanagement plan
6.
Diabetes affects kids but
managing it is not child’s play:
it’s a team sport
7. Be prepared for common Demergencies and know how to
prevent or manage them
8. T1D usually has an entourage:
know who the other “players”
are and keep an eye on them
9. What’s new and changing in
type 1 diabetes
10. Diabetes self care is a series of
never-ending choices; strive for
perfection but be satisfied with
excellence
3. Appreciate the normal flux of glucose levels in normal
individuals first!
Trick Question: How would you rate this person’s diabetes control?
4. One goal of diabetes care is managing glucose…
Hint: It takes TIME and PATIENCE!
16. How does a “basal” insulin work?
• Turns off or tones down
sugar coming out of the
liver
• Allows a reasonable
amount of sugar to
enter cells
• Keeps sugar levels
steady or in balance
between meals and
snacks.
17. Timely insulin facts
• Rapid insulin can’t
lower BG any sooner
than 20 minutes
• It peaks on average in
about 1 h 15 min
• It’s mostly gone in 2-4
hours
• Maximum fall in BG is
4 mg/dl/min (rare)
18. TIP: A standing insulin dose (or
regimen) is ALWAYS CHANGED LAST
• When troubleshooting a type 1 diabetes blood
sugar problem
• First consider…
– Food
– Timing
– Equipment
• BEFORE changing an insulin regimen
19. Why is the TDD so important?
½ TDD/24 = basal rate
Insulin on Board (IOB)
(2-8 hours)
500/TDD = carb ratio
Total
Daily
Dose
(TDD)
TARGET BG
1800/TDD = correction
20. Average TDD insulin ranges by age and weight
0.6-0.8 U/kg/d (toddler)
0.8-1.0 U/kg/d (child)
1.0-1.2 U/kg/d (teen)
21. Basal-Bolus: Example Calculations
30 units as glargine
Give dose at bedtime
TDD
60 units
~ 30 units divided as boluses
10 – 10 – 10 + snacks
OR…
60 units
500 rule
8.3 ~ 10
Insulin to
carbohydrate ratio
60 units
1800 rule
30
Correction factor
(aka sensitivity factor)
22. Adjust The TDD For A High Avg. BG or A1C
Example: someone with a TDD of 35 units and few lows.
A1c = 9%, so more insulin is needed: about 3.2 units.
23. Time to reach 100 mg/dl (at ~ 4 mg/dl/min)
Blood sugar
420
340
260
180
minutes
25. Timing of Bolus Insulin
(humalog/novolog/apidra)
High GI
Moderate GI
Low GI
BG Above
Target Range
30-40 min. prior
15-20 min. prior
0-5 min. prior
BG Within
Target Range
15-20 min. prior
0-5 min. prior
15-20 min. after
BG Below
Target Range
0-5 min. prior
15-20 min. after
30-40 min. after
26. Timing of Bolus Insulin vs. GI or BG
Low BG
OK
High BG
Low G.I.
Mod
High G.I.
-30
-15
0
Minutes from meal
15
30
29. Beware of delayed-action foods
•
•
•
•
Pizza
Pasta/noodles
Mexican foods
Fried foods
That slowly turn to sugar in body
30. “Fried-food revenge” and correction
BG = 194
6 unit correction @ 7AM
Fried food earlier
in evening @ 8PM
BG = 115
in 3 hours
31.
32. If insulin keeps us alive, as does
food, then why should one get
more attention than the other?
33. Because…
1) Most doctors are not
nutrition specialists
2) Diagnosing and
prescribing are what
we’re trained to do
3) Our health care system
downplays the role of
RD’s by not always
paying for those
services
4) Plus WE think we’re all
food experts anyway!
34. DON’T SHORT CHANGE THE MEAL PLAN
Food questions are
number one for most
parents and patients
Don’t use the “D” word.
It’s a meal plan.
Meal plans change
often after diagnosis
and should be
reviewed (at least)
yearly or for growth
37. The pancreas has an “off” switch for insulin
…and it’s triggered by exercise
38. Exercise is the wild card since…
• It can occur suddenly or
unexpectedly
• It can last for different periods
of time
• Intensity can shift up or down
• It’s hard to measure
• It’s impact on blood sugar can
vary
40. Meters are commodity items
“a commodity is the generic term for any marketable item
produced to satisfy wants or needs”
• The best BG meter is
the one you’ll use
• $10.41 for 50 strips
(Medicare 2013 rate)
• Lancing devices (avoid
the nerves)
• Ketone meter (get one!)
41. ISO and FDA allowable errors
“Glycemic Roulette”?
Diabetes Spectrum Volume 25, Number 3, 2012
ISO 15197 Standards for SMBG
43. CGM calibration advice
• A CGM’s accuracy is the sum of it’s variances.
• Variance is the difference from what is
measured and what is real
• So…minimize variance whenever possible
• Calibrate (if possible) when things are steady
• Wash hands; get proper sized blood sample
(repeat if needed)
• If you calibrate when high or low, do some more
later when back in your zone
• You can over-calibrate too.
44. Ponder’s Pumping Principles
1. An insulin pump is no better or worse than the
human being attached to it
2. Master carb counting first BEFORE pumping
3. Age does not limit who can pump insulin
4. Garbage in, garbage out: beware of the “pump
and dump” phenomenon
5. A good pump doctor behaves like a coach
6. Simple is a good place to start, but pumping
skills MUST advance over time
45. Ponder’s Pumping Principles
7. A good insulin pumper troubleshoots and
problem solves daily. It’s all about mastering
the PROCESS of pumping
8. Technology changes; people don’t
9. Self-consistency is a virtue
10. Everyone’s blood sugar fluxes; seek out your
own sugar patterns in the “chaos”
11. Success is always a relative thing
12. Don’t ever be afraid to start over
46. Why do lows happen at night?
•
•
•
•
•
Hormonal patterns
Lower insulin need
Insulin peaks?
Post-exercise effect
Snacking stacking?
Lower overnight insulin/add snack
47. Don’t pass up an opportunity to
correct a high (or low) BG
• Choose what you
consider “actionable”?
• BG above or below
chosen thresholds
• Consider recent and
impending actions
• Check your results
with BG levels
• Repeat as necessary
48. Check your targets often
• Make sure you hit
your target “zone”
sugar ( 30 mg/dl)
• Rapid-acting insulin
results are best
examined at 2-3
hours
• Results should
feedback to the next
attempt
“Practice makes better”
49. Curb your liver!
• The liver makes as
well as stores sugar
• A proper insulin level
“calms down” the
liver
• Aim for an in-range
sugar level (<120 mg/dl)
upon waking up each
day
55. Concrete thinkers*
can’t…
1. Consider a hypothesis
2. Consider multiple
possibilities in a
scenario
3. Systematically solve a
problem
4. Use combinatorial
logic
*Lasts until 15-17 years of age
*25% of adults are concrete thinkers.
56. ATTITUDE CHECK!
There are no “good” or
“bad” blood sugars
“In range”, “high”, “low”
Replace “testing” with
monitoring or checking
Beware of the “perfect”
record book! If you
EVEN LOOK at blood
sugars!
This whole good-bad thing
is stressing me out
57. TIPS FOR IMPROVING ADHERENCE
Your role is more like a
coach or cheerleader
The goal should be a
“normal” life, not just
“normal” blood sugars
Reward/praise the
EFFORT not the
OUTCOME
58. ISSUES FOR PARENTS AND SIBLINGS
Diabetes in a child will
test any marriage
Parents should best
share diabetes care
duties
Encourage couples time
Discuss early in course
Siblings often suffer in
silence
Fear and
misunderstanding
59. Know common reasons for lows
a)
b)
c)
d)
e)
f)
PROBLEM
Delayed meal/snack
Exercise/food/insulin
mismatch
Incorrect standing doses
or dosing ratios
Stacking insulin
Stress (wild card effect)
Post-exercise nighttime
a)
b)
c)
d)
e)
f)
USUAL FIX
Work on timing/remembering
Reduce insulin and/or increase
carbs, check BG before exercise
Check 2 hour BG patterns for
how well targets are being hit
Use bolus calculator/DIA factor
Keep list of unique responses
Eat snack with activity/less
overnight insulin/bigger
bedtime snack
60. Know common reasons for highs
a)
b)
c)
d)
e)
f)
g)
PROBLEM
Overeating (knowing/unknowingly)
High sugars 2 hrs. after meal
High fasting sugar
Damaged/outdated insulin
Stress (adrenaline response)
Insulin pump malfunction
Insulin omission
a)
b)
c)
d)
e)
f)
g)
USUAL FIX
Improve carb counting
Adjust meal dose/carbs
Check basal insulin/carbs
Toss open vials monthly
Pre-activity dose adjustment
Check site/tubing/program
Share responsibility
61. Master the art of ketone-annihilation
• Check ketones when BG > 300
• If any nausea or vomiting,
regardless of BG level
• During any illness, check
ketones periodically
• Watch: http://db.tt/00PIDcoG
• Diabetes Sick Day Rules (17 min)
62. Type 1 diabetes can
have sidekicks
• Thyroid disease
– Screen with antibodies
– Thyroid blood levels
• Celiac disease
– Screen with antibodies
– Formal Dx by GI doc
– Gluten-free
prevention?
63. Annual responsibilities
• Eye (retinal) exams
• Urine microalbumin
studies at start of teen
years or after 5 years
• Lipid profile (after 10)
• Hemoglobin A1C
(quarterly)
• Vitamin D levels(?)
64. Prior to 1980, 50% of people
with type 1 diabetes would
develop renal failure 10-20
years after onset of diabetes*
* Bruce Buckingham, MD
65. Most are now living normal lifespans
… individuals with type 1 diabetes
without renal disease achieve longterm survival comparable to the
general population.
Diabetologia. 2010 Jul 28. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/20665208
66. More from the DCCT…
“
We thus believe the dramatic
improvement in life expectancy
is likely true for the general
population with childhood onset
type 1 diabetes and not due to a
preferential participation of
healthier individuals in the EDC in
later years. Furthermore, the
improvement in life expectancy
is far greater than that seen in
the general population.
Diabetes, July 30, 2012 - DOI: 10.2337/db11-1625
“
68. The JDRF Closed Loop Pathway
1
Very Low Glucose a
Insulin Off Pump
START
6
Fully Automated
Insulin +
END
Anti-insulin
Closed Loop
2
3
Hypoglycemia
Minimizer
Hypo/Hyper
Minimizer
5
4
Fully Automated
Insulin
Closed Loop
Automated
Basal / Hybrid
Closed Loop
From Aaron Kowalski, PhD, JDRF Artificial Pancreas Presentation, 2008
www.jdrf.org/artificialpancreas
69. Insulin Action
• Even rapid acting analogs are too slow
• Speed of onset matters to reduce
hyperglycemia
• Duration of action matters to reduce
hypoglycemia
• Many companies working on solutions – let’s
look at one
72. Time in Range with Bihormonal AP
• 48 Plasma Glucose
• <70 – 0.7%
• 70-120 – 38%
• 70-180 – 68%
• Overnight PG
• <70 – 0.5%
• 70-120 – 62%
• 70-180 – 93%
73. Bihormonal AP
• Two pumps (or dualchambered pump)
• Insulin
• Glucagon
• Hand-held controller
• Under study in US
• Ambulatory studies
soon
• Several groups
studying (this from
Boston University)
Photo courtesy of Ed Damiano, PhD of Boston University
75. Islet Cell Transplantation
• Edmonton Protocol
– Long term, whole body immunosuppression
– Graft longevity a serious issue
– Availability of islets an even more serious issue
76. Encapsulation
• DRI encapsulation chamber
– Thumbnail sized device
– Implanted, vascularized, then human islets added
– Local immunosuppression, not whole body
– Islets easily replaced
77. Xenotransplantation
• Islet availability remains a critical limitation
• PERV free pig herd
• Additional physical protection required to
prevent hyper rejection
• Intraperitoneal alginate-encapsulated
neonatal porcine islet implants
• Bob Elliott, Living Cell Technologies from New
Zealand
78. LCT Example
CONCLUSION: This form of
xenotransplantation treatment has the
potential for sustained benefit in
human type 1 diabetics.
http://www.lctglobal.com/html/popups/popup_publicationView.php?documentcode=2081
79. What if it’s not just about insulin? Glucagon
http://diabetes.diabetesjournals.org/content/60/2/391.full.pdf
80. Without Glucagon Receptors No
Type 1 Metabolic Disorder
(in mice)
Average weekly nonfasting glucose
levels in Gcgr+/+
(solid) and Gcgr-/(open) after STZinduced beta cell
destruction.
Diamonds are fasting
averages for week 6.
http://diabetes.diabetesjournals.org/content/60/2/391.full.pdf
81. Suppressing Glucagon?
Taken together these findings indicate in mice
that type 1 diabetes can be converted into an
asymptomatic, benign, noncatabolic, insulinindependent disorder by elimination of glucagon
action. These studies support the clinical utility
of the development of potent Gcgr antagonists
and/or glucagon suppressors capable of
eliminating the lethal glucagon-dependent
component of type 1 diabetes.
87. “I haven't failed. I've just found 10,000
ways that won't work.” Thomas Edison
88. “Wisdom is not a product of schooling but of
the lifelong attempt to acquire it”
89. “Life is not a matter of holding good
cards, but of playing a poor hand well.”
R.L. Stevenson (1850-1894)
90. ” …we are going to
relentlessly chase perfection,
knowing full well we will not
catch it, because nothing is
perfect. But we are going to
relentlessly chase it, because
in the process we will catch
excellence. “
91. Is the future already here?
Lifespan with type 1 diabetes vs. without
80
75
DX'd 1980--??
Average American
70
Type 1 Diabetes
DX'd 1965-1980
Linear (Average American)
65
Log. (Type 1 Diabetes)
60
55
DX'd 1950-1964
50
1964
1980
1996
92. Take home message…
• Care today is fundamentally different from a
generation ago
• Complications are becoming rare and are
not inevitable
• Lifespan can be essentially normal
• Science is moving forward on many fronts
Hinweis der Redaktion
20 seconds
15 seconds
45 seconds
15 seconds
15 seconds
Picture of a complex machine with many working parts capable of failing
TitleThe carbohydrate counting in adolescents with type 1 diabetes (CCAT) study.AuthorsBishop, F. K.; Maahs, D. M.; Spiegel, G.; Owen, D.; Klingensmith, G. J.; Bortsov, A.; Thomas, J.; Mayer-Davis, E. J.Journal Diabetes Spectrum 2009 Vol. 22 No. 1 pp. 56-62 ISSN1944-7353DOI10.2337/diaspect.22.1.56URLhttp://spectrum.diabetesjournals.org/cgi/content/a...This article reports pilot study results evaluating the accuracy of carbohydrate counting among adolescents with type 1 diabetes. This cross-sectional observational study included 48 adolescents ages 12-18 years (mean 15.2±1.8 years) with type 1 diabetes of >1 year in duration (mean A1C 8.0±1.0%) who used insulin:carbohydrate (I:C) ratios for at least one meal per day. The adolescents were asked to assess the amount of carbohydrate in 32 foods commonly consumed by youths. Foods were presented either as food models or as actual food, with some items presented as standard serving sizes and some self-served by study participants. T-tests were used to assess the significance of over- or underestimation of carbohydrate content. For each meal, accuracy was categorized as accurate (within 10 grams), overestimated (by >10 grams), or underestimated (by >10 grams) based on the commonly used I:C ratio of 1 unit of insulin per 10 grams of carbohydrate. Only 23% of adolescents estimated daily carbohydrate within 10 grams of the true amount despite selection of common meals. For dinner meals, individuals with accurate estimation of carbohydrate grams had the lowest A1C values (7.69±0.82%, P=0.04). The pilot study provides preliminary evidence that adolescents with type 1 diabetes do not accurately count carbohydrates. Further data are needed on carbohydrate counting accuracy and other factors that affect glycemic control.
Figure 2. Within-subject variability of insulin detemir, NPH insulin, and insulin glargine are graphically shown by the width of a prediction interval containing 95% of the predicted values. The prediction intervals illustrating day-to-day variability in the pharmacodynamic response are exemplified for a subject with the same mean response with any given treatment (insulin detemir, NPH insulin, or insulin glargine). A: A subject with a mean GIR over 24 h of 1 mg · kg-1 · min-1 has a probability to experience an effect of less than half the usual effect (i.e., <0.5 mg · kg-1 · min-1) of 0.5% using insulin detemir, 16% with NPH insulin, and 7% with insulin glargine. B: Similarly, for a subject with a maximum effect of 2 mg · kg-1 · min-1, the probability of experiencing a maximum effect of more than twice the usual level (i.e., >4 mg · kg-1 · min-1) will be 0.1% if the subject uses insulin detemir, 6% with NPH insulin, and 3% with insulin glargine. Note: a linear scale has been used in this figure to improve readability of values, and therefore the prediction intervals are not distributed symmetrically around the mean.
Figure 1. Individual time-action profiles (glucose infusion rates over time) of the first nine patients randomized to insulin detemir (A), NPH insulin (B), or insulin glargine (C). The four clamps in one subject are summarized in one plot. A low within-subject variability is indicated by the four lines in one plot being close to each other (e.g., subject no. 204), whereas major deviations between the time-action profiles in one subject (e.g., subject no. 224) shows a high within-subject variability.
Figure 1. Individual time-action profiles (glucose infusion rates over time) of the first nine patients randomized to insulin detemir (A), NPH insulin (B), or insulin glargine (C). The four clamps in one subject are summarized in one plot. A low within-subject variability is indicated by the four lines in one plot being close to each other (e.g., subject no. 204), whereas major deviations between the time-action profiles in one subject (e.g., subject no. 224) shows a high within-subject variability.
15 seconds
25 seconds
Xenotransplantation. 2007 Mar;14(2):157-61Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation.Elliott RB, Escobar L, Tan PL, Muzina M, Zwain S, Buchanan C. Living Cell Technologies, Auckland, New Zealand.BACKGROUND: The long-term viability and function of transplanted encapsulated neonatal porcine islets was examined in a diabetic patient.METHODS AND RESULTS: A 41-yr-old Caucasian male with type 1 diabetes for 18 yr was given an intraperitoneal transplant of alginate-encapsulated porcine islets at the dose of 15,000 islet equivalents (IEQs)/kg bodyweight (total dose 1,305,000 IEQs) via laparoscopy. By 12 weeks following the transplant, his insulin dose was significantly reduced by 30% (P = 0.0001 by multiple regression tests) from 53 units daily prior to transplant. The insulin dose returned to the pre-transplant level at week 49. Improvement in glycaemic control continued as reflected by total glycatedhaemoglobin of 7.8% at 14 months from a pre-transplant level of 9.3%. Urinary porcine C-peptide peaked at 4 months (9.5 ng/ml) and remained detectable for 11 months (0.6 ng/ml). The patient was followed as part of a long-term microbiologic monitoring programme which subsequently showed no evidence of porcine viral or retroviral infection. At laparoscopy 9.5 yr after transplantation, abundant nodules were seen throughout the peritoneum. Biopsies of the nodules showed opacified capsules containing cell clusters that stained as live cells under fluorescence microscopy. Immunohistology noted sparse insulin and moderate glucagon staining cells. The retrieved capsules produced a small amount of insulin when placed in high glucose concentrations in vitro. An oral glucose tolerance test induced a small rise in serum of immuno-reactive insulin, identified as porcine by reversed phase high pressure liquid chromatography. CONCLUSION: This form of xenotransplantation treatment has the potential for sustained benefit in human type 1 diabetics.
15 seconds
Thomas Edison (Considered that greatest inventor of all time, 1846 - 1931):